Showing results (1591-1600 of 1,827) with videos related to
Sort By:
Pageof 183
Bone Marrow Transplantation|June 14, 2024
Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantationNormann Steiner, Radwan Massoud, Evgeny Klyuchnikov, et al.Bone Marrow Transplantation|April 23, 2022
Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMTMitja Nabergoj, Katya Mauff, Dietrich Beelen, et al.Transplantation and Cellular Therapy|April 12, 2022
Worldwide Network for Blood and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular TherapyAmal Alseraihy, Eoin McGrath, Dietger Niederwieser, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 5, 2019
Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working PartyAleksandar Radujkovic, Sascha Dietrich, Henric-Jan Blok, et al.Bone Marrow Transplantation|March 30, 2022
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWPFrancesco Onida, Giulia Sbianchi, Aleksandar Radujkovic, et al.Clinical Lung Cancer|September 20, 2021
Role of Postoperative Radiotherapy in the Management for Resected NSCLC - Decision Criteria in Clinical Routine Pre- and Post-LungARTKrisztian Süveg, Cecile Le Pechoux, Corinne Faivre-Finn, et al.Leukemia|May 23, 2021
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMTNicolaus Kröger, Giulia Sbianchi, Tiarlan Sirait, et al.Oncology Letters|August 20, 2019
Expression of the immune checkpoint receptor TIGIT in seminomaAndrea Hinsch, Niclas C Blessin, Ronald Simon, et al.HLA|June 27, 2024
The impact of MICB mismatches in unrelated haematopoietic stem cell transplantationElisa Maria Amann, Sowmya Gowdavally, Chrysanthi Tsamadou, et al.Hemasphere|January 26, 2023
Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMTAlexandros Spyridonidis, Myriam Labopin, Bipin Savani, et al.Pageof 183